DOCSLIB.ORG

Avantis-Us-Equity-Etf-Avus-Holdings

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Avantis-Us-Equity-Etf-Avus-Holdings Avantis U.S. Equity ETF as of July 2, 2021 Issue Name Ticker CUSIP ISIN SEDOL Share Quantity Contract Count Market Value Weight Apple Inc AAPL 037833100 US0378331005 2046251 370,063 0 $51,794,017.48 3.83% Microsoft Corp MSFT 594918104 US5949181045 2588173 168,735 0 $46,849,272.75 3.46% Amazon.com Inc AMZN 023135106 US0231351067 2000019 10,695 0 $37,549,931.10 2.78% Facebook Inc FB 30303M102 US30303M1027 B7TL820 53,334 0 $18,917,569.80 1.40% Alphabet Inc GOOGL 02079K305 US02079K3059 BYVY8G0 6,327 0 $15,850,084.05 1.17% Alphabet Inc-CL C GOOG 02079K107 US02079K1079 BYY88Y7 6,069 0 $15,623,912.22 1.16% Johnson & Johnson JNJ 478160104 US4781601046 2475833 80,004 0 $13,519,075.92 1.00% JPMorgan Chase & Co JPM 46625H100 US46625H1005 2190385 78,287 0 $12,215,120.61 0.90% PayPal Holdings Inc PYPL 70450Y103 US70450Y1038 BYW36M8 36,964 0 $10,728,431.36 0.79% Exxon Mobil Corp XOM 30231G102 US30231G1022 2326618 136,481 0 $8,621,504.77 0.64% Verizon Communications Inc VZ 92343V104 US92343V1044 2090571 142,153 0 $8,023,115.32 0.59% NVIDIA Corp NVDA 67066G104 US67066G1040 2379504 9,294 0 $7,616,247.12 0.56% Intel Corp INTC 458140100 US4581401001 2463247 130,831 0 $7,425,967.56 0.55% Berkshire Hathaway Inc BRK/B 084670702 US0846707026 2073390 26,035 0 $7,266,889.20 0.54% Bank of America Corp BAC 060505104 US0605051046 2295677 174,160 0 $7,166,684.00 0.53% Tesla Inc TSLA 88160R101 US88160R1014 B616C79 10,380 0 $7,046,982.00 0.52% Target Corp TGT 87612E106 US87612E1064 2259101 27,674 0 $6,823,854.92 0.50% Mastercard Inc MA 57636Q104 US57636Q1040 B121557 18,026 0 $6,760,290.78 0.50% Visa Inc V 92826C839 US92826C8394 B2PZN04 27,432 0 $6,546,098.16 0.48% Costco Wholesale Corp COST 22160K105 US22160K1051 2701271 16,037 0 $6,397,800.78 0.47% Union Pacific Corp UNP 907818108 US9078181081 2914734 28,123 0 $6,319,800.56 0.47% Applied Materials Inc AMAT 038222105 US0382221051 2046552 44,973 0 $6,213,469.68 0.46% Chevron Corp CVX 166764100 US1667641005 2838555 58,262 0 $6,179,850.34 0.46% NIKE Inc NKE 654106103 US6541061031 2640147 38,594 0 $6,165,005.56 0.46% Morgan Stanley MS 617446448 US6174464486 2262314 66,592 0 $6,128,461.76 0.45% Accenture PLC ACN G1151C101 IE00B4BNMY34 B4BNMY3 20,052 0 $6,112,651.68 0.45% Lowe's Cos Inc LOW 548661107 US5486611073 2536763 30,313 0 $5,932,557.23 0.44% Comcast Corp CMCSA 20030N101 US20030N1019 2044545 100,652 0 $5,880,089.84 0.43% Deere & Co DE 244199105 US2441991054 2261203 16,678 0 $5,878,995.00 0.43% Home Depot Inc/The HD 437076102 US4370761029 2434209 17,706 0 $5,713,726.20 0.42% Caterpillar Inc CAT 149123101 US1491231015 2180201 25,979 0 $5,657,187.04 0.42% Goldman Sachs Group Inc/The GS 38141G104 US38141G1040 2407966 15,077 0 $5,641,210.32 0.42% Wells Fargo & Co WFC 949746101 US9497461015 2649100 122,441 0 $5,518,415.87 0.41% Texas Instruments Inc TXN 882508104 US8825081040 2885409 28,682 0 $5,512,967.22 0.41% Eli Lilly & Co LLY 532457108 US5324571083 2516152 23,407 0 $5,476,301.72 0.41% Bristol-Myers Squibb Co BMY 110122108 US1101221083 2126335 77,997 0 $5,221,899.15 0.39% United Parcel Service Inc UPS 911312106 US9113121068 2517382 24,224 0 $5,124,102.72 0.38% Citigroup Inc C 172967424 US1729674242 2297907 72,442 0 $5,100,641.22 0.38% Moderna Inc MRNA 60770K107 US60770K1079 BGSXTS3 21,684 0 $5,080,561.20 0.38% Procter & Gamble Co/The PG 742718109 US7427181091 2704407 36,746 0 $4,993,781.40 0.37% American Express Co AXP 025816109 US0258161092 2026082 29,622 0 $4,991,307.00 0.37% Netflix Inc NFLX 64110L106 US64110L1061 2857817 9,165 0 $4,893,926.70 0.36% Walmart Inc WMT 931142103 US9311421039 2936921 34,489 0 $4,832,253.79 0.36% UnitedHealth Group Inc UNH 91324P102 US91324P1021 2917766 11,722 0 $4,798,517.92 0.35% Anthem Inc ANTM 036752103 US0367521038 BSPHGL4 12,246 0 $4,741,651.20 0.35% Lam Research Corp LRCX 512807108 US5128071082 2502247 7,395 0 $4,669,498.80 0.35% Micron Technology Inc MU 595112103 US5951121038 2588184 57,596 0 $4,626,686.68 0.34% Merck & Co Inc MRK 58933Y105 US58933Y1055 2778844 58,212 0 $4,575,463.20 0.34% Gilead Sciences Inc GILD 375558103 US3755581036 2369174 Avantis U.S. Equity ETF as of July 2, 2021 MIsseurcek N &a Cmoe Inc MTicRkKer 5CU89S3IP3Y105 UISSIN58933Y1055 2SE77D8O8L44 Share Quantity Contract Count Market Value Weight Gilead Sciences Inc GILD 375558103 US3755581036 2369174 65,457 0 $4,536,170.10 0.34% CSX Corp CSX 126408103 US1264081035 2160753 134,207 0 $4,372,464.06 0.32% General Motors Co GM 37045V100 US37045V1008 B665KZ5 72,285 0 $4,261,923.60 0.32% AT&T Inc T 00206R102 US00206R1023 2831811 145,584 0 $4,255,420.32 0.31% PepsiCo Inc PEP 713448108 US7134481081 2681511 28,568 0 $4,254,060.88 0.31% ConocoPhillips COP 20825C104 US20825C1045 2685717 67,025 0 $4,205,818.75 0.31% Adobe Inc ADBE 00724F101 US00724F1012 2008154 7,080 0 $4,198,935.60 0.31% FedEx Corp FDX 31428X106 US31428X1063 2142784 13,929 0 $4,170,064.02 0.31% Capital One Financial Corp COF 14040H105 US14040H1059 2654461 25,777 0 $4,057,299.80 0.30% Charles Schwab Corp/The SCHW 808513105 US8085131055 2779397 53,702 0 $3,909,505.60 0.29% Coca-Cola Co/The KO 191216100 US1912161007 2206657 66,287 0 $3,591,429.66 0.27% AbbVie Inc ABBV 00287Y109 US00287Y1091 B92SR70 31,082 0 $3,579,713.94 0.26% Norfolk Southern Corp NSC 655844108 US6558441084 2641894 13,197 0 $3,575,199.27 0.26% Ford Motor Co F 345370860 US3453708600 2615468 239,028 0 $3,568,688.04 0.26% Amgen Inc AMGN 031162100 US0311621009 2023607 13,842 0 $3,442,505.40 0.25% Cisco Systems Inc/Delaware CSCO 17275R102 US17275R1023 2198163 63,059 0 $3,376,178.86 0.25% Biogen Inc BIIB 09062X103 US09062X1037 2455965 9,670 0 $3,372,122.40 0.25% Pfizer Inc PFE 717081103 US7170811035 2684703 84,584 0 $3,360,522.32 0.25% Humana Inc HUM 444859102 US4448591028 2445063 7,273 0 $3,285,723.21 0.24% Walt Disney Co/The DIS 254687106 US2546871060 2270726 18,383 0 $3,255,813.13 0.24% Progressive Corp/The PGR 743315103 US7433151039 2705024 32,855 0 $3,251,659.35 0.24% QUALCOMM Inc QCOM 747525103 US7475251036 2714923 22,681 0 $3,233,856.98 0.24% TJX Cos Inc/The TJX 872540109 US8725401090 2989301 47,085 0 $3,213,551.25 0.24% Oracle Corp ORCL 68389X105 US68389X1054 2661568 38,905 0 $3,183,207.10 0.24% IDEXX Laboratories Inc IDXX 45168D104 US45168D1046 2459202 4,836 0 $3,134,695.20 0.23% Linde PLC LIN G5494J103 IE00BZ12WP82 BZ12WP8 10,541 0 $3,075,442.16 0.23% Occidental Petroleum Corp OXY 674599105 US6745991058 2655408 94,058 0 $3,064,409.64 0.23% T Rowe Price Group Inc TROW 74144T108 US74144T1088 2702337 14,987 0 $3,050,753.72 0.23% Intuit Inc INTU 461202103 US4612021034 2459020 6,000 0 $2,985,840.00 0.22% S&P Global Inc SPGI 78409V104 US78409V1044 BYV2325 7,073 0 $2,932,677.99 0.22% T-Mobile US Inc TMUS 872590104 US8725901040 B94Q9V0 19,530 0 $2,857,043.70 0.21% Broadcom Inc AVGO 11135F101 US11135F1012 BDZ78H9 6,100 0 $2,855,837.00 0.21% Ross Stores Inc ROST 778296103 US7782961038 2746711 22,527 0 $2,844,033.75 0.21% Zoetis Inc ZTS 98978V103 US98978V1035 B95WG16 14,714 0 $2,835,387.80 0.21% EOG Resources Inc EOG 26875P101 US26875P1012 2318024 33,029 0 $2,832,897.33 0.21% Honeywell International Inc HON 438516106 US4385161066 2020459 12,717 0 $2,814,526.44 0.21% Abbott Laboratories ABT 002824100 US0028241000 2002305 23,759 0 $2,804,512.36 0.21% PNC Financial Services Group Inc/The PNC 693475105 US6934751057 2692665 14,402 0 $2,776,561.58 0.21% Dow Inc DOW 260557103 US2605571031 BHXCF84 42,990 0 $2,730,294.90 0.20% US Bancorp USB 902973304 US9029733048 2736035 46,300 0 $2,665,491.00 0.20% Discover Financial Services DFS 254709108 US2547091080 B1YLC43 22,131 0 $2,660,146.20 0.20% Medtronic PLC MDT G5960L103 IE00BTN1Y115 BTN1Y11 20,974 0 $2,660,132.42 0.20% Automatic Data Processing Inc ADP 053015103 US0530151036 2065308 13,110 0 $2,641,402.80 0.20% Travelers Cos Inc/The TRV 89417E109 US89417E1091 2769503 17,119 0 $2,588,906.37 0.19% BlackRock Inc BLK 09247X101 US09247X1019 2494504 2,888 0 $2,580,803.44 0.19% Ameriprise Financial Inc AMP 03076C106 US03076C1062 B0J7D57 10,265 0 $2,575,693.80 0.19% Allstate Corp/The ALL 020002101 US0200021014 2019952 19,192 0 $2,556,950.16 0.19% Kroger Co/The KR 501044101 US5010441013 2497406 66,036 0 $2,533,801.32 0.19% Cummins Inc CMI 231021106 US2310211063 2240202 Avantis U.S. Equity ETF as of July 2, 2021 KIsrsougee Nr Caom/eThe KTiRcker 5CU01S0IP44101 UISSIN5010441013 2SE49D7O4L06 Share Quantity Contract Count Market Value Weight Cummins Inc CMI 231021106 US2310211063 2240202 10,429 0 $2,522,149.36 0.19% Truist Financial Corp TFC 89832Q109 US89832Q1094 BKP7287 44,548 0 $2,496,024.44 0.18% Estee Lauder Cos Inc/The EL 518439104 US5184391044 2320524 7,781 0 $2,470,934.36 0.18% Thermo Fisher Scientific Inc TMO 883556102 US8835561023 2886907 4,762 0 $2,444,429.84 0.18% Fortinet Inc FTNT 34959E109 US34959E1091 B5B2106 9,754 0 $2,419,382.16 0.18% Prudential Financial Inc PRU 744320102 US7443201022 2819118 23,419 0 $2,415,201.47 0.18% Devon Energy Corp DVN 25179M103 US25179M1036 2480677 82,589 0 $2,414,076.47 0.18% KKR & Co Inc KKR 48251W104 US48251W1045 BG1FRR1 39,721 0 $2,374,918.59 0.18% International Business Machines Corp IBM 459200101 US4592001014 2005973 16,938 0 $2,371,658.76 0.18% Synchrony Financial SYF 87165B103 US87165B1035 BP96PS6 47,293 0 $2,319,721.65 0.17% Advanced Micro Devices Inc AMD 007903107 US0079031078 2007849 24,154 0 $2,287,383.80 0.17% Pioneer Natural Resources Co PXD 723787107 US7237871071 2690830 13,673 0 $2,279,836.02 0.17% salesforce.com Inc CRM 79466L302 US79466L3024 2310525 9,172 0 $2,276,490.40 0.17% Corning Inc GLW 219350105 US2193501051 2224701 55,153 0 $2,272,303.60 0.17% Kansas City Southern KSU 485170302 US4851703029
Load more

Recommended publications
  • Pfizer's Bourla
    No. 3985 December 13, 2019 line success and business development. “In the next two years, we need to see how the pipeline is delivering,” he said. Bourla has been outspoken that when it comes to business development, he doesn’t see a mega-merger on the hori- zon. Instead, he said he is looking to bring in mid-stage clinical development assets to complement the internal pipeline. It sounds like investors can expect the company to be active on the business development front within those guard- rails. “I want to double it,” he said of the pipeline, which includes 92 projects right now. “And, we are going to double it by bringing in a lot of innovation to comple- ment what we distribute.” The company is focusing business de- velopment on six core therapeutic areas Pfizer’s Bourla: “I Think We Forgot as well, but Bourla indicated the company will be actively building out those areas both through internal investment and What It Looks Like To Grow” external collaboration. “We’re going to be JESSICA MERRILL [email protected] active because Pfizer is a very big plane and it cannot fly with one engine,” he said. fizer Inc. CEO Albert Bourla took in July it will merge the Upjohn business Bourla highlighted Pfizer’s recent acqui- over the top leadership spot from with Mylan NV to form a new generic drug sition of the cancer specialist Array Bio- PIan Read a year ago, but has quickly company to be called Viatris GMBH. Pharma for $11.4bn as an example of the executed on big changes poised to make The resulting Pfizer will be significantly kinds of deals the company will be pursu- Pfizer significantly smaller and faster smaller, with a 2020 annual revenue base ing.
    [Show full text]
  • Health Industry Business Communications Council
    Health Industry Business Communications Council Registered Labelers: Accredited Auto-ID Labeling Standards Argentina New MedTek Devices Pty Ltd Oxavita SRL Norseld Pty Ltd. Novadien Healthcare Pty Ltd The following companies Odontit S.A. (and/or their subsidiaries/ PAMPAMED S.R.L. Numedico Technologies Pty Ltd divisions) have applied PATEJIM SRL Opto Global Pty. Ltd. for a Labeler Identification Orthocell Limited Code (LIC) assignment with Austria Prolotus Technologies Pty Ltd HIBCC*. By doing so, they afreeze GmbH Red Milawa Pty Ltd dba Magic Mobility have demonstrated their AMI GmbH SDI Limited commitment to patient safety Bender Medsystems GmbH Signostics Ltd. and logistical efficiency for BHS Technologies GmbH Sirtex Medical Pty Ltd their customers, the industry Metasys Medizintechnik GmbH Smith & Nephew Surgical Pty. Ltd. and the public at large. PAA Laboratories GmbH Staminalift International Limited Safersonic Medizinprodukte Handels The Pipette Company Pty. Ltd. Any organization that is GmbH Thermo Electron Corporation interested in using the HIBC W & H Dentalwerk Burmoos GmbH Vush Pty Ltd uniform labeling system may apply for the assignment of VUSH STIMULATION Australia one or more LICs. William A Cook Australia Pty. Ltd. Adv. Surgical Design & Manufacture, Ltd. Last updated 9-21-2021 AirPhysio Pty Ltd Belgium Annalise-AI Pty Ltd 3M Europe Apollo Medical Imaging Technology Pty Advanced Medical Diagnostics SA/NV Ltd Analis SA/NV Benra Pty Ltd dba Gelflex Laboratories Baxter World Trade Bioclone Australia Pty. Ltd. Bio-Rad RSL Candelis, Inc. Bio-Rad Lab Inc Clinical Diag. Group DePuy Australia Pty. Ltd. Biosource Europe SA For more information, please dorsaVi Ltd Cilag NV contact the HIBCC office at: EC Certification Service GmbH Coris Bioconcept Fink Engineering Pty Ltd Fuji Hunt Photographic Chemicals NV 2525 E.
    [Show full text]
  • Active Labelers List Labeler ID Labeler Name Begin Date End Date 00002 ELI LILLY and COMPANY 01/01/1991 12/31/2078 00003 E.R
    Kentucky Medicaid Pharmacy 3Q2011 Active Labelers List Labeler ID Labeler Name Begin Date End Date 00002 ELI LILLY AND COMPANY 01/01/1991 12/31/2078 00003 E.R. SQUIBB & SONS, INC. 01/01/1991 12/31/2078 00004 HOFFMANN-LA ROCHE 01/01/1991 12/31/2078 00005 LEDERLE LABORATORIES 01/01/1991 12/31/2078 00006 MERCK & CO., INC. 01/01/1991 12/31/2078 00007 GLAXOSMITHKLINE 01/01/1991 12/31/2078 00008 WYETH LABORATORIES 01/01/1991 12/31/2078 00009 PFIZER, INC 01/01/1991 12/31/2078 00013 PFIZER, INC. 01/01/1991 12/31/2078 00014 PFIZER, INC 01/01/1991 12/31/2078 00015 MEAD JOHNSON AND COMPANY 01/01/1991 12/31/2078 00023 ALLERGAN INC 01/01/1991 12/31/2078 00024 SANOFI-AVENTIS, US LLC 01/01/1991 12/31/2078 00025 PFIZER, INC. 01/01/1991 12/31/2078 00026 BAYER CORPORATION PHARMACEUTICAL DIV. 01/01/1991 12/31/2078 00028 NOVARTIS 01/01/1991 10/01/2011 00029 GLAXOSMITHKLINE 01/01/1991 12/31/2078 00031 A. H. ROBINS 01/01/1991 12/31/2078 00032 SOLVAY PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00037 MEDA PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00039 SANOFI-AVENTIS, US LLC 01/01/1991 12/31/2078 00045 ORTHO-MCNEIL-JANSSEN PHARMECEUTICAL, IN 01/01/1991 12/31/2078 00046 AYERST LABORATORIES 01/01/1991 12/31/2078 00049 PFIZER, INC 01/01/1991 12/31/2078 00051 UNIMED PHARMACEUTICALS, INC 10/01/1997 12/31/2078 00052 ORGANON USA INC.
    [Show full text]
  • PFIZER INC. (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-3619 PFIZER INC. (Exact name of registrant as specified in its charter) Delaware 13-5315170 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 235 East 42nd Street, New York, New York 10017 (Address of principal executive offices) (zip code) (212) 733-2323 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.05 par value PFE New York Stock Exchange 0.000% Notes due 2020 PFE20A New York Stock Exchange 0.250% Notes due 2022 PFE22 New York Stock Exchange 1.000% Notes due 2027 PFE27 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • UNITED NATIONS SYSTEM Annual Statistical Report 2005
    Annual Statistical Report 2005 • Procurement of Goods & Services • All Sources of Funding • UNDP Funding • Procurement from DAC Member Countries • International & National Project Personnel • United Nations Volunteers • Fellowships Published: July 2006 by UNITED NATIONS SYSTEM Annual Statistical Report 2005 Procurement of Goods and Services • All Sources of Funding • UNDP Funding Procurement from DAC Member Countries International & National Project Personnel United Nations Volunteers Fellowships July 2006 Copyright © 2006 by the United Nations Development Programme 1 UN Plaza, New York, NY 10017, USA All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, photocopying, recording or otherwise, without prior permission of UNDP/IAPSO. TABLE OF CONTENTS INTRODUCTION...................................................................................................................... 1 GLOASSARY OF TERMS ...................................................................................................... 3 EXECUTIVE SUMMARY: ALL SOURCES OF FUNDING (UN SYSTEM)............................ 4 PROCUREMENT OF GOODS AND SERVICES - ALL SOURCES OF FUNDING Procurement of goods by country of procurement and services by country of head office ................................................................................................... 9 Procurement by UN agency ......................................................................................
    [Show full text]
  • FTSE Developed
    2 FTSE Russell Publications 19 August 2021 FTSE Developed Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 1&1 AG <0.005 GERMANY Alcon AG 0.05 SWITZERLAND Aozora Bank <0.005 JAPAN 3i Group 0.03 UNITED Ald SA <0.005 FRANCE APA Group 0.01 AUSTRALIA KINGDOM Alexandria Real Estate Equity 0.04 USA Appen <0.005 AUSTRALIA 3M Company 0.19 USA Alexion Pharm 0.07 USA Apple Inc. 3.61 USA A P Moller - Maersk A 0.02 DENMARK Alfa Laval 0.02 SWEDEN Applied Materials 0.22 USA A P Moller - Maersk B 0.03 DENMARK Alfresa Holdings <0.005 JAPAN Aptiv PLC 0.07 USA a2 Milk 0.01 NEW ZEALAND Align Technology Inc 0.08 USA Aramark 0.01 USA A2A 0.01 ITALY Alimentation Couche-Tard B 0.05 CANADA Arcelor Mittal 0.04 NETHERLANDS AAC Technologies Holdings 0.01 HONG KONG Alleghany 0.02 USA Arch Capital Gp 0.03 USA Aalberts NV 0.01 NETHERLANDS Allegion PLC 0.02 USA Archer Daniels Midland 0.06 USA ABB 0.1 SWITZERLAND Allegro 0.01 POLAND Argenx S.E 0.03 BELGIUM Abbott Laboratories 0.34 USA Alliant Energy 0.02 USA Ariake Japan <0.005 JAPAN AbbVie Inc 0.33 USA Allianz SE 0.17 GERMANY Arista Networks 0.04 USA ABC-Mart <0.005 JAPAN Allstate Corp 0.07 USA Aristocrat Leisure 0.03 AUSTRALIA Abiomed Inc 0.02 USA Ally Financial 0.03 USA Arkema 0.01 FRANCE ABN AMRO Bank NV 0.01 NETHERLANDS Alnylam Pharmaceuticals 0.03 USA Aroundtown SA 0.02 GERMANY Accenture Cl A 0.31 USA Alony Hetz Properties & Inv <0.005 ISRAEL Arrow Electronics 0.01 USA Acciona S.A.
    [Show full text]
  • Participating Labelers.Xlsx
    Labeler Labeler Effective Labeler End Code Labeler Name Date Date 00002 ELI LILLY AND COMPANY 1/1/1991 12/31/2299 00003 E.R. SQUIBB & SONS, INC. 1/1/1991 12/31/2299 00004 HOFFMANN-LA ROCHE 1/1/1991 12/31/2299 00005 LEDERLE LABORATORIES 1/1/1991 12/31/2299 00006 MERCK & CO., INC. 1/1/1991 12/31/2299 00007 GLAXOSMITHKLINE 1/1/1991 12/31/2299 00008 WYETH LABORATORIES 1/1/1991 12/31/2299 00009 PFIZER, INC 1/1/1991 12/31/2299 00013 PFIZER, INC. 1/1/1991 12/31/2299 00015 MEAD JOHNSON AND COMPANY 1/1/1991 12/31/2299 00023 ALLERGAN INC 1/1/1991 12/31/2299 00024 SANOFI-AVENTIS, US LLC 1/1/1991 12/31/2299 00025 PFIZER, INC. 1/1/1991 12/31/2299 00026 BAYER CORPORATION PHARMACEUTICAL DIV. 1/1/1991 12/31/2299 00028 NOVARTIS 1/1/1991 12/31/2299 00029 GLAXOSMITHKLINE 1/1/1991 12/31/2299 00031 A. H. ROBINS 1/1/1991 12/31/2299 00032 SOLVAY PHARMACEUTICALS, INC. 1/1/1991 12/31/2299 00037 MEDA PHARMACEUTICALS, INC. 1/1/1991 12/31/2299 00039 SANOFI-AVENTIS, US LLC 1/1/1991 12/31/2299 00045 ORTHO-MCNEIL-JANSSEN PHARMECEUTICAL, IN 1/1/1991 12/31/2299 00046 AYERST LABORATORIES 1/1/1991 12/31/2299 00049 PFIZER, INC 1/1/1991 12/31/2299 00051 UNIMED PHARMACEUTICALS, INC 10/1/1997 12/31/2299 00052 ORGANON USA INC. 1/1/1991 12/31/2299 00053 CSL BEHRING 1/1/1991 12/31/2299 00054 ROXANE LABORATORIES, INC.
    [Show full text]
  • UNITED NATIONS SYSTEM Annual Statistical Report 2005
    Annual Statistical Report 2005 • Procurement of Goods & Services • All Sources of Funding • UNDP Funding • Procurement from DAC Member Countries • International & National Project Personnel • United Nations Volunteers • Fellowships Published: July 2006 by UNITED NATIONS SYSTEM Annual Statistical Report 2005 Procurement of Goods and Services • All Sources of Funding • UNDP Funding Procurement from DAC Member Countries International & National Project Personnel United Nations Volunteers Fellowships July 2006 Copyright © 2006 by the United Nations Development Programme 1 UN Plaza, New York, NY 10017, USA All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, photocopying, recording or otherwise, without prior permission of UNDP/IAPSO. TABLE OF CONTENTS INTRODUCTION...................................................................................................................... 1 GLOASSARY OF TERMS ...................................................................................................... 3 EXECUTIVE SUMMARY: ALL SOURCES OF FUNDING (UN SYSTEM)............................ 4 PROCUREMENT OF GOODS AND SERVICES - ALL SOURCES OF FUNDING Procurement of goods by country of procurement and services by country of head office ................................................................................................... 9 Procurement by UN agency ......................................................................................
    [Show full text]
  • Downloaded to a PC Or PDA
    DDT Issue10 NOVEMBER05 11/28/05 4:27 PM Page 1 NOVEMBER/DECEMBER 2005 Vol 5 No 10 IN THIS ISSUE Corporate Profiles 12 Drug Delivery Technologies 76 Excipients, Polymers, Liposomes & Lipids 92 Contract Pharmaceutical & Biological Development Services 98 Laboratory Testing & Analytical Equipment & Sotware 109 Technology Spotlight 113 The science & business of specialty pharma, biotechnology, and drug delivery www.drugdeliverytech.com DDT Issue10 NOVEMBER05 11/7/05 3:41 PM Page 2 NO BARRIERS. NEW FRONTIERS. COMPLEX CHALLENGES, INNOVATIVE SOLUTIONS. For 35 years, ALZA has led the drug delivery industry in developing extraordinary products based on our transdermal, oral, implantable, and liposomal delivery platforms. More than 30 products in 80 countries are based on ALZA’s novel drug delivery and targeting technologies. Today, ALZA’s dedicated researchers and scientists are addressing the complex challenges of delivering small molecules and biopharmaceuticals, with the commitment to create better medicines that improve healthcare for patients worldwide. Visit www.alza.com to learn more. © 2003 ALZA Corporation LEADING THE NEXT GENERATION OF DRUG DELIVERY DDT Issue10 NOVEMBER05 11/5/05 8:12 AM Page 3 Inhalation and transdermal technology from 3M w Novel Dry Powder Inhaler Ne Gives you the edge in a from MicroDose Technologiescompetitive environment The MicroDose dry powder inhaler, CFC-free metered dose inhaler and transdermal drug delivery systems customized to your specifications ៑ A wide variety of components to meet your needs ៑ Nearly 50 years’ experience in inhalation drug delivery technology and skin adhesion products ៑ Fully integrated development and manufacturing processes ៑ Global regulatory expertise ៑ Project management support available from concept through commercialization Developing proven solutions that enable your success.
    [Show full text]
  • 2019 MED-Project Annual Report
    2019 MED-Project Annual Report Alameda County, California March 1, 2020 Prepared By: MED-Project LLC Submitted To: Alameda County, Department of Environmental Health Table of Contents Executive Summary ............................................................................................................. 4 Participating Producers ....................................................................................................... 5 Collection Method and Weight ............................................................................................ 5 A. Kiosks .................................................................................................................................... 5 B. Mail-Back Packages ................................................................................................................. 5 C. Take-Back Events ................................................................................................................... 5 D. Total Weight of Collected Unwanted Medicine ........................................................................... 5 Kiosk Drop-Off Locations, Mail-Back Distribution, and Take-Back Events ......................... 5 Kiosk Drop-Off Locations ......................................................................................................... 6 Mail-Back Package Distribution Locations .................................................................................. 6 Number of Mail-Back Packages Provided to Home-Bound and Under Served Residents ...............
    [Show full text]
  • Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017)
    Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017) Participating Drug Company Parent Drug Company 3M Corporation 3M Corporation 3M Critical and Chronic Care 3M Corporation 3M Drug Delivery Systems 3M Corporation 3M Infection Prevention 3M Corporation 3M Oral Care 3M Corporation AbbVie Inc. AbbVie Inc. ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals Inc. Accord Healthcare Inc. Accord Healthcare Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Actavis Generics Teva Pharmaceuticals USA, Inc. Actavis Pharma, Inc. (only for labeler code 52544) Allergan, Inc. Actelion Pharmaceuticals US, Inc. Actelion Pharmaceuticals US, Inc. Advanced Vision Research Inc. d.b.a. Akorn Consumer Health Akorn, Inc. Aegerion Pharmaceuticals, Inc. Aegerion Pharmaceuticals, Inc. Afaxys Inc. Afaxys Inc. Afaxys Pharmaceuticals (a division of Afaxys Inc.) Afaxys Inc. Affordable Pharmaceuticals LLC Braintree Laboratories Inc. Akorn Animal Health, Inc. Akorn, Inc. Akorn, Inc. Akorn, Inc. Akrimax Pharmaceuticals, LLC Akrimax Pharmaceuticals, LLC AKRON COATING & ADHESIVES AKRON COATING & ADHESIVES Alcon Laboratories, Inc. Novartis Group Companies Allergan Sales LLC Allergan, Inc. Allergan USA, Inc. Allergan, Inc. Allergan, Inc. Allergan, Inc. Alva-Amco Pharmacal Companies, Inc. Alva-Amco Pharmacal Companies, Inc. AMAG Pharma USA, Inc. AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Amarin Corp Amarin Pharma, Inc. Amarin Corp. PLC Amarin Pharma, Inc. Amarin Pharma, Inc. Amarin Pharma, Inc. Amarin Pharmaceuticals Ireland Ltd. Amarin Pharma, Inc. American Regent, Inc. Daiichi Sankyo, Inc. Amerisource Health Services Corporation DBA: American Health Amerisource Health Services Corporation DBA: American Health Packaging Packaging Amgen Inc. Amgen Inc. Amgen USA Amgen Inc. Amneal Pharmaceuticals LLC Amneal Pharmaceuticals LLC Anchen Pharmaceuticals, Inc.
    [Show full text]
  • Washington State 2020 Annual Report (PDF)
    First MED-Project Annual Report For 2019 Operating Period State of Washington Due July 1, 2020 Prepared By: MED-Project WA, LLC Submitted To: Washington State Department of Health Table of Contents I. Executive Summary ............................................................................................................... 3 II. Annual Budget ...................................................................................................................... 3 Table 1: Annual Budget .................................................................................................................. 4 Appendix A ................................................................................................................................ 5 List of Covered Manufacturers ......................................................................................................... 5 Table 2: List of Covered Manufacturers.......................................................................................... 21 2 I. Executive Summary MED-Project WA, LLC’s (“MED-Project”) Product Stewardship Plan for Covered Drugs from Households (“Plan”) was approved by the Washington State Department of Health (the "Department") on May 25, 2020. Per the Plan, MED-Project will initiate operations by November 21, 2020, which is within 180 days of the Plan approval date. This first Annual Report for the 2019 reporting period was requested by the Department and includes an update to the annual budget that occurred after the submission of the proposed Plan and
    [Show full text]